Literature DB >> 16886199

Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.

Manish Munjal1, Mahmoud A Elsohly, Michael A Repka.   

Abstract

The objectives of the present research investigations were to (i) elucidate the mechanism for the oxidative degradation of Delta(9)-tetrahydrocannabinol (THC) in polymer matrix systems prepared by a hot-melt fabrication procedure, and (ii) study the potential for controlling these mechanisms to reduce the degradation of THC in solid dosage formulations. Various factors considered and applied included drug-excipient compatibility, use of antioxidants, cross-linking in polymeric matrices, microenvironment pH, and moisture effect. Instability of THC in polyethylene oxide (PEO)-vitamin E succinate (VES) patches was determined to be due to chemical interaction between the drug and the vitamin as well as with the atmospheric oxygen. Of the different classes and mechanisms of antioxidants studied, quenching of oxygen by reducing agents, namely, ascorbic acid was the most effective in stabilizing THC in PEO-VES matrices. Only 5.8% of the drug degraded in the ascorbic acid-containing patch as compared to the control (31.6%) after 2 months of storage at 40 degrees C. This coupled with the cross-linking extent and adjustment of the pH microenvironment, which seemed to have an impact on the THC degradation, might be effectively utilized towards stabilization of the drug in these polymeric matrices and other pharmaceutical dosage forms. These studies are relevant to the development of a stable transmucosal matrix system for the therapeutic delivery of amorphous THC. Copyright 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886199      PMCID: PMC2921982          DOI: 10.1002/jps.20711

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist.

Authors:  S I Badawy; R C Williams; D L Gilbert
Journal:  Pharm Dev Technol       Date:  1999-08       Impact factor: 3.133

Review 2.  Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition.

Authors:  S Hovorka; C Schöneich
Journal:  J Pharm Sci       Date:  2001-03       Impact factor: 3.534

Review 3.  Stabilization of pharmaceuticals to oxidative degradation.

Authors:  Kenneth C Waterman; Roger C Adami; Karen M Alsante; Jinyang Hong; Margaret S Landis; Franco Lombardo; Christopher J Roberts
Journal:  Pharm Dev Technol       Date:  2002-01       Impact factor: 3.133

4.  Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.

Authors:  S I Badawy; R C Williams; D L Gilbert
Journal:  J Pharm Sci       Date:  1999-04       Impact factor: 3.534

5.  Influence of peroxide impurities in polyethylene glycols on drug stability.

Authors:  J W McGinity; J A Hill; A L La Via
Journal:  J Pharm Sci       Date:  1975-02       Impact factor: 3.534

6.  Polymeric systems for amorphous Delta 9-tetrahydrocannabinol produced by a hot-melt method. Part I: chemical and thermal stability during processing.

Authors:  Manish Munjal; Steven P Stodghill; Mahmoud A Elsohly; Michael A Repka
Journal:  J Pharm Sci       Date:  2006-08       Impact factor: 3.534

7.  Use of the antioxidant BHT in asymmetric membrane tablet coatings to stabilize the core to the acid catalyzed peroxide oxidation of a thioether drug.

Authors:  Michael J Puz; Barbara A Johnson; Brendan J Murphy
Journal:  Pharm Dev Technol       Date:  2005       Impact factor: 3.133

8.  Antioxidants in pharmaceutical products.

Authors:  M J Akers
Journal:  J Parenter Sci Technol       Date:  1982 Sep-Oct

9.  Autoxidation of polysorbates.

Authors:  M Donbrow; E Azaz; A Pillersdorf
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

10.  Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography.

Authors:  K P Flora; J C Cradock; J P Davignon
Journal:  J Chromatogr       Date:  1981-02-06
View more
  8 in total

1.  Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.

Authors:  Sampada B Upadhye; Swapnil J Kulkarni; Soumyajit Majumdar; Mitchell A Avery; Waseem Gul; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

Review 2.  Applications of hot-melt extrusion for drug delivery.

Authors:  Michael A Repka; Soumyajit Majumdar; Sunil Kumar Battu; Ramesh Srirangam; Sampada B Upadhye
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

Review 3.  Continuous twin screw granulation - An advanced alternative granulation technology for use in the pharmaceutical industry.

Authors:  Suresh Bandari; Dinesh Nyavanandi; Venkata Raman Kallakunta; Kartik Yadav Janga; Sandeep Sarabu; Arun Butreddy; Michael A Repka
Journal:  Int J Pharm       Date:  2020-03-16       Impact factor: 5.875

4.  Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations.

Authors:  Valentino J Stella
Journal:  Pharm Res       Date:  2013-05-02       Impact factor: 4.200

5.  Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.

Authors:  Nagendra S Punyamurthula; Tushar Hingorani; Goutham Adelli; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Drug Dev Ind Pharm       Date:  2015-12-07       Impact factor: 3.225

Review 6.  Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.

Authors:  Arun Radhakrishnan; Gowthamarajan Kuppusamy; Sivasankaran Ponnusankar; Nikhitha K Shanmukhan
Journal:  Pharmacogenomics J       Date:  2019-12-10       Impact factor: 3.550

7.  Δ9-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits.

Authors:  Pranjal S Taskar; Akash Patil; Prit Lakhani; Eman Ashour; Waseem Gul; Mahmoud A ElSohly; Brian Murphy; Soumyajit Majumdar
Journal:  Transl Vis Sci Technol       Date:  2019-09-19       Impact factor: 3.283

8.  Kinetics of CBD, Δ9-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions.

Authors:  Wuttichai Jaidee; Ittipon Siridechakorn; Siwames Nessopa; Vanuchawan Wisuitiprot; Nathareen Chaiwangrach; Kornkanok Ingkaninan; Neti Waranuch
Journal:  Cannabis Cannabinoid Res       Date:  2021-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.